Medfinder
Back to blog

Updated: January 1, 2026

Why Is Vevye So Hard to Find? [Explained for 2026]

Author

Peter Daggett

Peter Daggett

Empty pharmacy shelf with magnifying glass icon

Struggling to find Vevye in stock? Learn why this dry eye medication can be difficult to locate and what you can do about it in 2026.

Why Is Vevye Hard to Find?

If you've been prescribed Vevye (cyclosporine ophthalmic solution 0.1%) and hit a wall trying to fill your prescription, you're not alone. Despite not being on the FDA's official shortage list, Vevye is a newer specialty dry eye medication that isn't stocked at every pharmacy — and prior authorization hurdles can make it feel even more elusive.

The good news: with the right tools and knowledge, most patients can get Vevye filled quickly. This guide breaks down exactly why Vevye can be hard to find — and how to fix that.

What Is Vevye?

Vevye is a prescription eye drop approved by the FDA on May 30, 2023. It contains cyclosporine 0.1% in a unique water-free, preservative-free semifluorinated alkane solution. It is the first and only cyclosporine-based product approved for both the signs and symptoms of dry eye disease, with clinical benefits demonstrated as early as 15 days and sustained over 12 months.

You instill one drop in each eye twice daily, approximately 12 hours apart. One 2 mL bottle lasts about 30 days.

Why Do Some Patients Have Trouble Finding Vevye?

1. It's a Newer Specialty Medication

Vevye only received FDA approval in 2023, making it one of the newest dry eye treatments on the market. Many retail pharmacies don't routinely stock newer specialty eye drops until patient demand in their area is established. Your neighborhood pharmacy may simply not carry it yet.

2. Prior Authorization Barriers

Even when Vevye is technically covered by your insurance plan, many insurers require prior authorization (PA) before they'll pay for it. Your doctor's office must submit documentation proving the medical necessity of Vevye. This back-and-forth can delay your prescription by days or even weeks. Harrow's VEVYE Access for All program (launched March 2025) through specialty pharmacy PhilRx was specifically created to eliminate this PA hurdle.

3. Step Therapy Requirements

Some insurance plans require patients to fail an older or cheaper medication first — like generic cyclosporine 0.05% — before they'll cover Vevye. This is called step therapy, and it's a common access barrier for newer branded medications.

4. Not Stocked at All Retail Pharmacies

While Vevye is available through major wholesale distributors McKesson, Cardinal Health, and Cencora — meaning it can be shipped to any retail pharmacy within 24 hours of an order — many pharmacies simply haven't ordered it yet.

5. High List Price Creates Complexity

Vevye's retail list price is approximately $900-$1,070 per 2 mL bottle. While manufacturer savings programs can bring this down dramatically — to $0 for eligible commercially insured patients or $59 through PhilRx — the high list price can cause friction for patients unaware of these options.

Is Vevye on the FDA Shortage List?

No. As of 2026, Vevye is not on the FDA's official drug shortage list. It is commercially available through major wholesale distributors and can be ordered by any retail pharmacy. The challenges patients face are primarily about insurance access barriers and pharmacy stocking patterns — not a true supply shortage.

What Can You Do Right Now?

  • Use Medfinder to search for pharmacies that have Vevye in stock near you before calling around.
  • Ask your eye doctor to send the prescription to PhilRx via their EMR for the VEVYE Access for All $59 program — no prior auth needed.
  • Apply for the VEVYE Savings Card at vevye.com/savings-program — commercially insured patients may pay $0.
  • Ask your pharmacy to order Vevye through their wholesale distributor — it usually ships within 24 hours.
  • If insurance is blocking you, have your doctor submit a prior authorization with supporting dry eye documentation.

Is There a Generic Version of Vevye?

No. There is currently no FDA-approved generic version of Vevye (cyclosporine ophthalmic solution 0.1%). Related alternatives your doctor may consider include generic cyclosporine 0.05% (generic Restasis), which costs significantly less. Talk to your eye care provider about whether an alternative is right for your situation.

The Bottom Line

Vevye isn't impossible to find — it just requires knowing where to look and how to navigate the insurance and pharmacy system. Harrow's access programs mean most patients can get Vevye for $59 or less. Don't give up at the first roadblock.

Want more help? Read our guide on how to find Vevye in stock near you.

Also see: Alternatives to Vevye if you can't fill your prescription.

Search for Vevye availability now at Medfinder.com.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Vevye also looked for:

Generic Cyclosporine 0.05%Restasis (cyclosporine 0.05%)Cequa (cyclosporine 0.09%)Xiidra (lifitegrast 5%)Miebo (perfluorohexyloctane)

29,339 have already found their meds with Medfinder.

Start your search today.

29K+
5-star ratingTrusted by 29,339 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?